Incidence and risk factors of pneumococcal pneumonia in adults: a population-based study
Background Infection caused by Streptococcus pneumoniae, mainly invasive pneumococcal disease (IPD) and pneumococcal pneumonia (PP), are a major public health problem worldwide. This study investigated population-based incidence and risk of PP among Catalonian persons ≥ 50 years-old with and without...
Saved in:
| Published in | BMC pulmonary medicine Vol. 23; no. 1; pp. 200 - 11 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
08.06.2023
BioMed Central Ltd Springer Nature B.V BMC |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1471-2466 1471-2466 |
| DOI | 10.1186/s12890-023-02497-2 |
Cover
| Abstract | Background
Infection caused by Streptococcus pneumoniae, mainly invasive pneumococcal disease (IPD) and pneumococcal pneumonia (PP), are a major public health problem worldwide. This study investigated population-based incidence and risk of PP among Catalonian persons ≥ 50 years-old with and without specific underlying conditions/comorbidities, examining the influence of single and multi-comorbidities in the risk of suffering PP.
Methods
Population-based cohort study involving 2,059,645 persons ≥ 50 years-old in Catalonia, Spain, who were retrospectively followed between 01/01/2017-31/12/2018. The Catalonian information system for development of research in primary care (SIDIAP) was used to establish baseline characteristics of the cohort (comorbidities/underlying conditions), and PP cases were collected from discharge codes (ICD-10: J13) of the 68 referral Catalonian hospitals.
Results
Global incidence rate (IR) was 90.7 PP cases per 100,000 person-years, with a 7.6% (272/3592) case-fatality rate (CFR). Maximum IRs emerged among persons with history of previous IPD or all-cause pneumonia, followed by haematological neoplasia (475.0), HIV-infection (423.7), renal disease (384.9), chronic respiratory disease (314.7), liver disease (232.5), heart disease (221.4), alcoholism (204.8), solid cancer (186.2) and diabetes (159.6). IRs were 42.1, 89.9, 201.1, 350.9, 594.3 and 761.2 in persons with 0, 1, 2, 3, 4 and ≥ 5 comorbidities, respectively. In multivariable analyses, HIV-infection (hazard ratio [HR]: 5.16; 95% CI: 3.57–7.46), prior all-cause pneumonia (HR: 3.96; 95% CI: 3.45–4.55), haematological neoplasia (HR: 2.71; 95% CI: 2.06–3.57), chronic respiratory disease (HR: 2.66; 95% CI: 2.47–2.86) and prior IPD (HR: 2.56; 95% CI: 2.03–3.24) were major predictors for PP.
Conclusion
Apart of increasing age and immunocompromising conditions (classically recognised as high-risk conditions), history of prior IPD/pneumonia, presence of chronic pulmonary/respiratory disease and/or co-existing multi-comorbidity (i.e., two or more underlying conditions) are major risk factors for PP in adults, with an excess risk near to immunocompromised subjects. Redefining risk categories for PP, including all the above-mentioned conditions into the high-risk category, could be necessary to improve prevention strategies in middle-aged and older adults. |
|---|---|
| AbstractList | Infection caused by Streptococcus pneumoniae, mainly invasive pneumococcal disease (IPD) and pneumococcal pneumonia (PP), are a major public health problem worldwide. This study investigated population-based incidence and risk of PP among Catalonian persons ≥ 50 years-old with and without specific underlying conditions/comorbidities, examining the influence of single and multi-comorbidities in the risk of suffering PP.BACKGROUNDInfection caused by Streptococcus pneumoniae, mainly invasive pneumococcal disease (IPD) and pneumococcal pneumonia (PP), are a major public health problem worldwide. This study investigated population-based incidence and risk of PP among Catalonian persons ≥ 50 years-old with and without specific underlying conditions/comorbidities, examining the influence of single and multi-comorbidities in the risk of suffering PP.Population-based cohort study involving 2,059,645 persons ≥ 50 years-old in Catalonia, Spain, who were retrospectively followed between 01/01/2017-31/12/2018. The Catalonian information system for development of research in primary care (SIDIAP) was used to establish baseline characteristics of the cohort (comorbidities/underlying conditions), and PP cases were collected from discharge codes (ICD-10: J13) of the 68 referral Catalonian hospitals.METHODSPopulation-based cohort study involving 2,059,645 persons ≥ 50 years-old in Catalonia, Spain, who were retrospectively followed between 01/01/2017-31/12/2018. The Catalonian information system for development of research in primary care (SIDIAP) was used to establish baseline characteristics of the cohort (comorbidities/underlying conditions), and PP cases were collected from discharge codes (ICD-10: J13) of the 68 referral Catalonian hospitals.Global incidence rate (IR) was 90.7 PP cases per 100,000 person-years, with a 7.6% (272/3592) case-fatality rate (CFR). Maximum IRs emerged among persons with history of previous IPD or all-cause pneumonia, followed by haematological neoplasia (475.0), HIV-infection (423.7), renal disease (384.9), chronic respiratory disease (314.7), liver disease (232.5), heart disease (221.4), alcoholism (204.8), solid cancer (186.2) and diabetes (159.6). IRs were 42.1, 89.9, 201.1, 350.9, 594.3 and 761.2 in persons with 0, 1, 2, 3, 4 and ≥ 5 comorbidities, respectively. In multivariable analyses, HIV-infection (hazard ratio [HR]: 5.16; 95% CI: 3.57-7.46), prior all-cause pneumonia (HR: 3.96; 95% CI: 3.45-4.55), haematological neoplasia (HR: 2.71; 95% CI: 2.06-3.57), chronic respiratory disease (HR: 2.66; 95% CI: 2.47-2.86) and prior IPD (HR: 2.56; 95% CI: 2.03-3.24) were major predictors for PP.RESULTSGlobal incidence rate (IR) was 90.7 PP cases per 100,000 person-years, with a 7.6% (272/3592) case-fatality rate (CFR). Maximum IRs emerged among persons with history of previous IPD or all-cause pneumonia, followed by haematological neoplasia (475.0), HIV-infection (423.7), renal disease (384.9), chronic respiratory disease (314.7), liver disease (232.5), heart disease (221.4), alcoholism (204.8), solid cancer (186.2) and diabetes (159.6). IRs were 42.1, 89.9, 201.1, 350.9, 594.3 and 761.2 in persons with 0, 1, 2, 3, 4 and ≥ 5 comorbidities, respectively. In multivariable analyses, HIV-infection (hazard ratio [HR]: 5.16; 95% CI: 3.57-7.46), prior all-cause pneumonia (HR: 3.96; 95% CI: 3.45-4.55), haematological neoplasia (HR: 2.71; 95% CI: 2.06-3.57), chronic respiratory disease (HR: 2.66; 95% CI: 2.47-2.86) and prior IPD (HR: 2.56; 95% CI: 2.03-3.24) were major predictors for PP.Apart of increasing age and immunocompromising conditions (classically recognised as high-risk conditions), history of prior IPD/pneumonia, presence of chronic pulmonary/respiratory disease and/or co-existing multi-comorbidity (i.e., two or more underlying conditions) are major risk factors for PP in adults, with an excess risk near to immunocompromised subjects. Redefining risk categories for PP, including all the above-mentioned conditions into the high-risk category, could be necessary to improve prevention strategies in middle-aged and older adults.CONCLUSIONApart of increasing age and immunocompromising conditions (classically recognised as high-risk conditions), history of prior IPD/pneumonia, presence of chronic pulmonary/respiratory disease and/or co-existing multi-comorbidity (i.e., two or more underlying conditions) are major risk factors for PP in adults, with an excess risk near to immunocompromised subjects. Redefining risk categories for PP, including all the above-mentioned conditions into the high-risk category, could be necessary to improve prevention strategies in middle-aged and older adults. Infection caused by Streptococcus pneumoniae, mainly invasive pneumococcal disease (IPD) and pneumococcal pneumonia (PP), are a major public health problem worldwide. This study investigated population-based incidence and risk of PP among Catalonian persons ≥ 50 years-old with and without specific underlying conditions/comorbidities, examining the influence of single and multi-comorbidities in the risk of suffering PP. Population-based cohort study involving 2,059,645 persons ≥ 50 years-old in Catalonia, Spain, who were retrospectively followed between 01/01/2017-31/12/2018. The Catalonian information system for development of research in primary care (SIDIAP) was used to establish baseline characteristics of the cohort (comorbidities/underlying conditions), and PP cases were collected from discharge codes (ICD-10: J13) of the 68 referral Catalonian hospitals. Global incidence rate (IR) was 90.7 PP cases per 100,000 person-years, with a 7.6% (272/3592) case-fatality rate (CFR). Maximum IRs emerged among persons with history of previous IPD or all-cause pneumonia, followed by haematological neoplasia (475.0), HIV-infection (423.7), renal disease (384.9), chronic respiratory disease (314.7), liver disease (232.5), heart disease (221.4), alcoholism (204.8), solid cancer (186.2) and diabetes (159.6). IRs were 42.1, 89.9, 201.1, 350.9, 594.3 and 761.2 in persons with 0, 1, 2, 3, 4 and ≥ 5 comorbidities, respectively. In multivariable analyses, HIV-infection (hazard ratio [HR]: 5.16; 95% CI: 3.57-7.46), prior all-cause pneumonia (HR: 3.96; 95% CI: 3.45-4.55), haematological neoplasia (HR: 2.71; 95% CI: 2.06-3.57), chronic respiratory disease (HR: 2.66; 95% CI: 2.47-2.86) and prior IPD (HR: 2.56; 95% CI: 2.03-3.24) were major predictors for PP. Apart of increasing age and immunocompromising conditions (classically recognised as high-risk conditions), history of prior IPD/pneumonia, presence of chronic pulmonary/respiratory disease and/or co-existing multi-comorbidity (i.e., two or more underlying conditions) are major risk factors for PP in adults, with an excess risk near to immunocompromised subjects. Redefining risk categories for PP, including all the above-mentioned conditions into the high-risk category, could be necessary to improve prevention strategies in middle-aged and older adults. Background Infection caused by Streptococcus pneumoniae, mainly invasive pneumococcal disease (IPD) and pneumococcal pneumonia (PP), are a major public health problem worldwide. This study investigated population-based incidence and risk of PP among Catalonian persons ≥ 50 years-old with and without specific underlying conditions/comorbidities, examining the influence of single and multi-comorbidities in the risk of suffering PP. Methods Population-based cohort study involving 2,059,645 persons ≥ 50 years-old in Catalonia, Spain, who were retrospectively followed between 01/01/2017-31/12/2018. The Catalonian information system for development of research in primary care (SIDIAP) was used to establish baseline characteristics of the cohort (comorbidities/underlying conditions), and PP cases were collected from discharge codes (ICD-10: J13) of the 68 referral Catalonian hospitals. Results Global incidence rate (IR) was 90.7 PP cases per 100,000 person-years, with a 7.6% (272/3592) case-fatality rate (CFR). Maximum IRs emerged among persons with history of previous IPD or all-cause pneumonia, followed by haematological neoplasia (475.0), HIV-infection (423.7), renal disease (384.9), chronic respiratory disease (314.7), liver disease (232.5), heart disease (221.4), alcoholism (204.8), solid cancer (186.2) and diabetes (159.6). IRs were 42.1, 89.9, 201.1, 350.9, 594.3 and 761.2 in persons with 0, 1, 2, 3, 4 and ≥ 5 comorbidities, respectively. In multivariable analyses, HIV-infection (hazard ratio [HR]: 5.16; 95% CI: 3.57–7.46), prior all-cause pneumonia (HR: 3.96; 95% CI: 3.45–4.55), haematological neoplasia (HR: 2.71; 95% CI: 2.06–3.57), chronic respiratory disease (HR: 2.66; 95% CI: 2.47–2.86) and prior IPD (HR: 2.56; 95% CI: 2.03–3.24) were major predictors for PP. Conclusion Apart of increasing age and immunocompromising conditions (classically recognised as high-risk conditions), history of prior IPD/pneumonia, presence of chronic pulmonary/respiratory disease and/or co-existing multi-comorbidity (i.e., two or more underlying conditions) are major risk factors for PP in adults, with an excess risk near to immunocompromised subjects. Redefining risk categories for PP, including all the above-mentioned conditions into the high-risk category, could be necessary to improve prevention strategies in middle-aged and older adults. BackgroundInfection caused by Streptococcus pneumoniae, mainly invasive pneumococcal disease (IPD) and pneumococcal pneumonia (PP), are a major public health problem worldwide. This study investigated population-based incidence and risk of PP among Catalonian persons ≥ 50 years-old with and without specific underlying conditions/comorbidities, examining the influence of single and multi-comorbidities in the risk of suffering PP.MethodsPopulation-based cohort study involving 2,059,645 persons ≥ 50 years-old in Catalonia, Spain, who were retrospectively followed between 01/01/2017-31/12/2018. The Catalonian information system for development of research in primary care (SIDIAP) was used to establish baseline characteristics of the cohort (comorbidities/underlying conditions), and PP cases were collected from discharge codes (ICD-10: J13) of the 68 referral Catalonian hospitals.ResultsGlobal incidence rate (IR) was 90.7 PP cases per 100,000 person-years, with a 7.6% (272/3592) case-fatality rate (CFR). Maximum IRs emerged among persons with history of previous IPD or all-cause pneumonia, followed by haematological neoplasia (475.0), HIV-infection (423.7), renal disease (384.9), chronic respiratory disease (314.7), liver disease (232.5), heart disease (221.4), alcoholism (204.8), solid cancer (186.2) and diabetes (159.6). IRs were 42.1, 89.9, 201.1, 350.9, 594.3 and 761.2 in persons with 0, 1, 2, 3, 4 and ≥ 5 comorbidities, respectively. In multivariable analyses, HIV-infection (hazard ratio [HR]: 5.16; 95% CI: 3.57–7.46), prior all-cause pneumonia (HR: 3.96; 95% CI: 3.45–4.55), haematological neoplasia (HR: 2.71; 95% CI: 2.06–3.57), chronic respiratory disease (HR: 2.66; 95% CI: 2.47–2.86) and prior IPD (HR: 2.56; 95% CI: 2.03–3.24) were major predictors for PP.ConclusionApart of increasing age and immunocompromising conditions (classically recognised as high-risk conditions), history of prior IPD/pneumonia, presence of chronic pulmonary/respiratory disease and/or co-existing multi-comorbidity (i.e., two or more underlying conditions) are major risk factors for PP in adults, with an excess risk near to immunocompromised subjects. Redefining risk categories for PP, including all the above-mentioned conditions into the high-risk category, could be necessary to improve prevention strategies in middle-aged and older adults. Abstract Background Infection caused by Streptococcus pneumoniae, mainly invasive pneumococcal disease (IPD) and pneumococcal pneumonia (PP), are a major public health problem worldwide. This study investigated population-based incidence and risk of PP among Catalonian persons ≥ 50 years-old with and without specific underlying conditions/comorbidities, examining the influence of single and multi-comorbidities in the risk of suffering PP. Methods Population-based cohort study involving 2,059,645 persons ≥ 50 years-old in Catalonia, Spain, who were retrospectively followed between 01/01/2017-31/12/2018. The Catalonian information system for development of research in primary care (SIDIAP) was used to establish baseline characteristics of the cohort (comorbidities/underlying conditions), and PP cases were collected from discharge codes (ICD-10: J13) of the 68 referral Catalonian hospitals. Results Global incidence rate (IR) was 90.7 PP cases per 100,000 person-years, with a 7.6% (272/3592) case-fatality rate (CFR). Maximum IRs emerged among persons with history of previous IPD or all-cause pneumonia, followed by haematological neoplasia (475.0), HIV-infection (423.7), renal disease (384.9), chronic respiratory disease (314.7), liver disease (232.5), heart disease (221.4), alcoholism (204.8), solid cancer (186.2) and diabetes (159.6). IRs were 42.1, 89.9, 201.1, 350.9, 594.3 and 761.2 in persons with 0, 1, 2, 3, 4 and ≥ 5 comorbidities, respectively. In multivariable analyses, HIV-infection (hazard ratio [HR]: 5.16; 95% CI: 3.57–7.46), prior all-cause pneumonia (HR: 3.96; 95% CI: 3.45–4.55), haematological neoplasia (HR: 2.71; 95% CI: 2.06–3.57), chronic respiratory disease (HR: 2.66; 95% CI: 2.47–2.86) and prior IPD (HR: 2.56; 95% CI: 2.03–3.24) were major predictors for PP. Conclusion Apart of increasing age and immunocompromising conditions (classically recognised as high-risk conditions), history of prior IPD/pneumonia, presence of chronic pulmonary/respiratory disease and/or co-existing multi-comorbidity (i.e., two or more underlying conditions) are major risk factors for PP in adults, with an excess risk near to immunocompromised subjects. Redefining risk categories for PP, including all the above-mentioned conditions into the high-risk category, could be necessary to improve prevention strategies in middle-aged and older adults. Background Infection caused by Streptococcus pneumoniae, mainly invasive pneumococcal disease (IPD) and pneumococcal pneumonia (PP), are a major public health problem worldwide. This study investigated population-based incidence and risk of PP among Catalonian persons [greater than or equal to] 50 years-old with and without specific underlying conditions/comorbidities, examining the influence of single and multi-comorbidities in the risk of suffering PP. Methods Population-based cohort study involving 2,059,645 persons [greater than or equal to] 50 years-old in Catalonia, Spain, who were retrospectively followed between 01/01/2017-31/12/2018. The Catalonian information system for development of research in primary care (SIDIAP) was used to establish baseline characteristics of the cohort (comorbidities/underlying conditions), and PP cases were collected from discharge codes (ICD-10: J13) of the 68 referral Catalonian hospitals. Results Global incidence rate (IR) was 90.7 PP cases per 100,000 person-years, with a 7.6% (272/3592) case-fatality rate (CFR). Maximum IRs emerged among persons with history of previous IPD or all-cause pneumonia, followed by haematological neoplasia (475.0), HIV-infection (423.7), renal disease (384.9), chronic respiratory disease (314.7), liver disease (232.5), heart disease (221.4), alcoholism (204.8), solid cancer (186.2) and diabetes (159.6). IRs were 42.1, 89.9, 201.1, 350.9, 594.3 and 761.2 in persons with 0, 1, 2, 3, 4 and [greater than or equal to] 5 comorbidities, respectively. In multivariable analyses, HIV-infection (hazard ratio [HR]: 5.16; 95% CI: 3.57-7.46), prior all-cause pneumonia (HR: 3.96; 95% CI: 3.45-4.55), haematological neoplasia (HR: 2.71; 95% CI: 2.06-3.57), chronic respiratory disease (HR: 2.66; 95% CI: 2.47-2.86) and prior IPD (HR: 2.56; 95% CI: 2.03-3.24) were major predictors for PP. Conclusion Apart of increasing age and immunocompromising conditions (classically recognised as high-risk conditions), history of prior IPD/pneumonia, presence of chronic pulmonary/respiratory disease and/or co-existing multi-comorbidity (i.e., two or more underlying conditions) are major risk factors for PP in adults, with an excess risk near to immunocompromised subjects. Redefining risk categories for PP, including all the above-mentioned conditions into the high-risk category, could be necessary to improve prevention strategies in middle-aged and older adults. Keywords: Incidence, Pneumococcal pneumonia, Risk factors, Multimorbidity, Adults Infection caused by Streptococcus pneumoniae, mainly invasive pneumococcal disease (IPD) and pneumococcal pneumonia (PP), are a major public health problem worldwide. This study investigated population-based incidence and risk of PP among Catalonian persons [greater than or equal to] 50 years-old with and without specific underlying conditions/comorbidities, examining the influence of single and multi-comorbidities in the risk of suffering PP. Global incidence rate (IR) was 90.7 PP cases per 100,000 person-years, with a 7.6% (272/3592) case-fatality rate (CFR). Maximum IRs emerged among persons with history of previous IPD or all-cause pneumonia, followed by haematological neoplasia (475.0), HIV-infection (423.7), renal disease (384.9), chronic respiratory disease (314.7), liver disease (232.5), heart disease (221.4), alcoholism (204.8), solid cancer (186.2) and diabetes (159.6). IRs were 42.1, 89.9, 201.1, 350.9, 594.3 and 761.2 in persons with 0, 1, 2, 3, 4 and [greater than or equal to] 5 comorbidities, respectively. In multivariable analyses, HIV-infection (hazard ratio [HR]: 5.16; 95% CI: 3.57-7.46), prior all-cause pneumonia (HR: 3.96; 95% CI: 3.45-4.55), haematological neoplasia (HR: 2.71; 95% CI: 2.06-3.57), chronic respiratory disease (HR: 2.66; 95% CI: 2.47-2.86) and prior IPD (HR: 2.56; 95% CI: 2.03-3.24) were major predictors for PP. Apart of increasing age and immunocompromising conditions (classically recognised as high-risk conditions), history of prior IPD/pneumonia, presence of chronic pulmonary/respiratory disease and/or co-existing multi-comorbidity (i.e., two or more underlying conditions) are major risk factors for PP in adults, with an excess risk near to immunocompromised subjects. Redefining risk categories for PP, including all the above-mentioned conditions into the high-risk category, could be necessary to improve prevention strategies in middle-aged and older adults. |
| ArticleNumber | 200 |
| Audience | Academic |
| Author | de Diego-Cabanes, Cinta Vila-Córcoles, Angel Satué-Gracia, Eva M. Ribas-Seguí, Domingo Rodríguez-Casado, Clara Forcadell-Perisa, María J. Torras-Vives, Verónica Vila-Rovira, Angel Ochoa-Gondar, Olga |
| Author_xml | – sequence: 1 givenname: Olga surname: Ochoa-Gondar fullname: Ochoa-Gondar, Olga organization: Primary Health Care Service “Camp de Tarragona”, Institut Català de la Salut – sequence: 2 givenname: Verónica surname: Torras-Vives fullname: Torras-Vives, Verónica organization: Primary Health Care Service “Camp de Tarragona”, Institut Català de la Salut – sequence: 3 givenname: Cinta surname: de Diego-Cabanes fullname: de Diego-Cabanes, Cinta email: mcdiego.tgn.ics@gencat.cat organization: Primary Health Care Service “Camp de Tarragona”, Institut Català de la Salut, Unitat de Suport a la Recerca of Tarragona, Institut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol) – sequence: 4 givenname: Eva M. surname: Satué-Gracia fullname: Satué-Gracia, Eva M. organization: Primary Health Care Service “Camp de Tarragona”, Institut Català de la Salut, Unitat de Suport a la Recerca of Tarragona, Institut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol) – sequence: 5 givenname: Angel surname: Vila-Rovira fullname: Vila-Rovira, Angel organization: Primary Health Care Service “Camp de Tarragona”, Institut Català de la Salut – sequence: 6 givenname: María J. surname: Forcadell-Perisa fullname: Forcadell-Perisa, María J. organization: Primary Health Care Service “Camp de Tarragona”, Institut Català de la Salut – sequence: 7 givenname: Domingo surname: Ribas-Seguí fullname: Ribas-Seguí, Domingo organization: Primary Health Care Service “Camp de Tarragona”, Institut Català de la Salut – sequence: 8 givenname: Clara surname: Rodríguez-Casado fullname: Rodríguez-Casado, Clara organization: Information System for the Improvement of Research in Primary Care (SIDIAP), Primary Care Research Institute Jordi Gol, Universitat Autonoma de Barcelona – sequence: 9 givenname: Angel surname: Vila-Córcoles fullname: Vila-Córcoles, Angel organization: Primary Health Care Service “Camp de Tarragona”, Institut Català de la Salut, Unitat de Suport a la Recerca of Tarragona, Institut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol) |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37291502$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkktv1DAUhSNURB_wB1igSGzYpPgZO2xQVfEYqRIbkNhZN34MHjJ2sJOi_ns8D9pOhSpkRXaccz7nHt_T6ijEYKvqJUbnGMv2bcZEdqhBhJaHdaIhT6oTzARuCGvbo3vr4-o05xVCWEhOn1XHVJAOc0ROqu-LoL2xQdsagqmTzz9rB3qKKdfR1WOw8zrqqDUM-5fgofahBjMPU35XQz3GcR5g8jE0PWRr6jzN5uZ59dTBkO2L_XxWffv44evl5-bqy6fF5cVVo1skp0Zoy4izEgmERCeYk5Z2omMGDOedc4ID5ob1mjPGW0NE3yOCEKK8M473PT2rFjuuibBSY_JrSDcqglfbjZiWCtLk9WAV66W0QLXAjDECvLMt1dSgtnMUpMaFRXesOYxw8xuG4RaIkdpkrnaZq5K52mauSHG937nGuV9bo22YEgwHv3L4JfgfahmvC5Nw3PKuEN7sCSn-mm2e1NpnbYcBgo1zVkSWS5Qc44309QPpKs4plIQ3KoGoJC2-Uy2h1O2Di-VgvYGqC8EJFUi2rKjO_6Eqw9i116XXnC_7B4ZX9yu9LfFvOxWB3Al0ijkn65T207Y1CtkPj6dIHlj_K_r9heUiDkub7tJ4xPUHwSr8Dg |
| CitedBy_id | crossref_primary_10_1016_j_vaccine_2025_126992 crossref_primary_10_3390_healthcare12232490 crossref_primary_10_3390_jcm14020389 crossref_primary_10_1016_j_jinf_2024_106405 crossref_primary_10_1093_infdis_jiae088 crossref_primary_10_1186_s12985_024_02591_9 crossref_primary_10_1097_QCO_0000000000001005 crossref_primary_10_1177_20503121251319168 |
| Cites_doi | 10.1016/s0264-410x(99)00122-x 10.1086/431521 10.1186/1471-2334-8-96 10.1007/s00408-020-00349-y 10.1080/21645515.2021.1923348 10.1186/s12879-018-3096-7 10.1093/cid/cix549 10.1016/j.rmed.2018.02.007 10.1007/s40273-019-00805-5 10.1080/14760584.2020.1874929 10.1055/s-2005-925523 10.1016/j.medcli.2012.09.034 10.1371/journal.pone.0060273 10.3390/pathogens9040259 10.14236/jhi.v19i3.806 10.1093/cid/ciaa1045 10.1007/s10096-019-03485-3 10.1080/14760584.2021.1880328 10.1093/oxfordjournals.aje.a009804 10.1016/j.jvacx.2023.100264 10.1016/j.vaccine.2018.11.056 10.1016/j.ijid.2015.05.003 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2023 2023. The Author(s). COPYRIGHT 2023 BioMed Central Ltd. 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2023 – notice: 2023. The Author(s). – notice: COPYRIGHT 2023 BioMed Central Ltd. – notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TO 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM ADTOC UNPAY DOA |
| DOI | 10.1186/s12890-023-02497-2 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository – sequence: 6 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 1471-2466 |
| EndPage | 11 |
| ExternalDocumentID | oai_doaj_org_article_4b88ea3c714442a59e63c3d069f3a8c1 10.1186/s12890-023-02497-2 PMC10251659 A752370864 37291502 10_1186_s12890_023_02497_2 |
| Genre | Journal Article |
| GeographicLocations | Spain |
| GeographicLocations_xml | – name: Spain |
| GrantInformation_xml | – fundername: This work was supported by a grant from the “Fondo de Investigación Sanitaria” of the ”Instituto de Salud Carlos III” (call 2020) for the “Acción Estratégica en Salud 2020/2030 (code file PI20/01223), cofinanced by the European Union through the “Fondo Europeo de Desarrollo Regional” (FEDER). grantid: code file PI20/01223 – fundername: This work was supported by a grant from the "Fondo de Investigación Sanitaria" of the "Instituto de Salud Carlos III" (call 2020) for the "Acción Estratégica en Salud 2020/2030 (code file PI20/01223), cofinanced by the European Union through the "Fondo Europeo de Desarrollo Regional" (FEDER). grantid: code file PI20/01223 – fundername: ; grantid: code file PI20/01223 |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5GY 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABUWG ACGFO ACGFS ACIHN ACPRK ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS EMB EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 UKHRP W2D WOQ WOW XSB AAYXX CITATION -A0 3V. ACRMQ ADINQ ALIPV C24 CGR CUY CVF ECM EIF NPM 7TO 7XB 8FK AZQEC DWQXO H94 K9. PKEHL PQEST PQUKI PRINS 7X8 5PM 2VQ 4.4 ADTOC AHSBF C1A EJD H13 IPNFZ RIG UNPAY |
| ID | FETCH-LOGICAL-c608t-7ce42fe807007974f8e39794dad559ff75a15d4bc54456d27bb02000359df5bb3 |
| IEDL.DBID | M48 |
| ISSN | 1471-2466 |
| IngestDate | Tue Oct 14 14:57:58 EDT 2025 Sun Oct 26 04:14:26 EDT 2025 Tue Sep 30 17:13:36 EDT 2025 Thu Sep 04 16:02:27 EDT 2025 Sat Oct 11 05:52:02 EDT 2025 Mon Oct 20 22:19:12 EDT 2025 Mon Oct 20 16:16:37 EDT 2025 Thu Jan 02 22:31:56 EST 2025 Thu Apr 24 23:10:05 EDT 2025 Wed Oct 01 03:22:40 EDT 2025 Sat Sep 06 07:21:55 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Adults Pneumococcal pneumonia Risk factors Incidence Multimorbidity |
| Language | English |
| License | 2023. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. cc-by |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c608t-7ce42fe807007974f8e39794dad559ff75a15d4bc54456d27bb02000359df5bb3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12890-023-02497-2 |
| PMID | 37291502 |
| PQID | 2827038261 |
| PQPubID | 44785 |
| PageCount | 11 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_4b88ea3c714442a59e63c3d069f3a8c1 unpaywall_primary_10_1186_s12890_023_02497_2 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10251659 proquest_miscellaneous_2824685119 proquest_journals_2827038261 gale_infotracmisc_A752370864 gale_infotracacademiconefile_A752370864 pubmed_primary_37291502 crossref_citationtrail_10_1186_s12890_023_02497_2 crossref_primary_10_1186_s12890_023_02497_2 springer_journals_10_1186_s12890_023_02497_2 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-06-08 |
| PublicationDateYYYYMMDD | 2023-06-08 |
| PublicationDate_xml | – month: 06 year: 2023 text: 2023-06-08 day: 08 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | BMC pulmonary medicine |
| PublicationTitleAbbrev | BMC Pulm Med |
| PublicationTitleAlternate | BMC Pulm Med |
| PublicationYear | 2023 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC |
| References | 2497_CR15 2497_CR16 JD - Berild (2497_CR23) 2020; 9 2497_CR13 2497_CR14 Centers for Disease Control and Prevention (2497_CR2) 1997; 46 Y - Shao (2497_CR27) 2020; 19 2497_CR18 A Navarro-Torné (2497_CR4) 2021; 17 DS - Fedson (2497_CR3) 1999; 17 MM - García-Gil (2497_CR17) 2011; 19 2497_CR12 2497_CR10 P - Klemets (2497_CR29) 2008; 8 DM - Musher (2497_CR8) 2017; 65 MA - Said (2497_CR5) 2013; 8 M - Treskova (2497_CR26) 2019; 37 A - Torres (2497_CR6) 2018; 137 RE - Guevara (2497_CR30) 1999; 149 MH - Kyaw (2497_CR7) 2005; 192 DW - Hosmer (2497_CR20) 1999 C - Bonnave (2497_CR22) 2019; 38 AJ - Leidner (2497_CR25) 2019; 37 D - Hurley (2497_CR28) 2021; 73 MS - Niederman (2497_CR24) 2021; 20 2497_CR9 A Vila-Córcoles (2497_CR11) 2018; 18 A Torres (2497_CR19) 2013; 140 A - Ortqvist (2497_CR1) 2005; 26 2497_CR21 |
| References_xml | – volume: 17 start-page: 11 issue: Suppl 1 year: 1999 ident: 2497_CR3 publication-title: Vaccine doi: 10.1016/s0264-410x(99)00122-x – volume: 192 start-page: 377 year: 2005 ident: 2497_CR7 publication-title: J Infect Dis doi: 10.1086/431521 – ident: 2497_CR16 – volume: 8 start-page: 96 year: 2008 ident: 2497_CR29 publication-title: BMC Infect Dis doi: 10.1186/1471-2334-8-96 – ident: 2497_CR18 – ident: 2497_CR21 doi: 10.1007/s00408-020-00349-y – volume: 17 start-page: 3670 issue: 10 year: 2021 ident: 2497_CR4 publication-title: Hum Vaccin Immunother doi: 10.1080/21645515.2021.1923348 – volume: 18 start-page: 196 year: 2018 ident: 2497_CR11 publication-title: BMC Infect Dis doi: 10.1186/s12879-018-3096-7 – ident: 2497_CR14 – volume: 65 start-page: 1736 issue: 10 year: 2017 ident: 2497_CR8 publication-title: Clin Infect Dis doi: 10.1093/cid/cix549 – volume: 137 start-page: 6 year: 2018 ident: 2497_CR6 publication-title: Respir Med doi: 10.1016/j.rmed.2018.02.007 – volume: 37 start-page: 1093 issue: 9 year: 2019 ident: 2497_CR26 publication-title: PharmacoEconomics doi: 10.1007/s40273-019-00805-5 – volume: 19 start-page: 1141 issue: 12 year: 2020 ident: 2497_CR27 publication-title: Expert Rev Vaccines doi: 10.1080/14760584.2020.1874929 – volume: 26 start-page: 563 year: 2005 ident: 2497_CR1 publication-title: Semin Respir Crit Care Med doi: 10.1055/s-2005-925523 – volume-title: Applied Survival Analysis. Regression modeling of time to Event Data year: 1999 ident: 2497_CR20 – volume: 140 start-page: 223e1 issue: 5 year: 2013 ident: 2497_CR19 publication-title: Med Clin (Barc) doi: 10.1016/j.medcli.2012.09.034 – ident: 2497_CR15 – volume: 8 start-page: e60273 year: 2013 ident: 2497_CR5 publication-title: PLoS ONE doi: 10.1371/journal.pone.0060273 – ident: 2497_CR9 – ident: 2497_CR13 – volume: 9 start-page: 259 issue: 4 year: 2020 ident: 2497_CR23 publication-title: Pathogens doi: 10.3390/pathogens9040259 – volume: 19 start-page: 135 issue: 3 year: 2011 ident: 2497_CR17 publication-title: Inf Prim Care doi: 10.14236/jhi.v19i3.806 – volume: 73 start-page: e1489 year: 2021 ident: 2497_CR28 publication-title: Clin Infect Dis doi: 10.1093/cid/ciaa1045 – volume: 38 start-page: 785 issue: 4 year: 2019 ident: 2497_CR22 publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/s10096-019-03485-3 – volume: 20 start-page: 243 issue: 3 year: 2021 ident: 2497_CR24 publication-title: Expert Rev Vaccines doi: 10.1080/14760584.2021.1880328 – volume: 149 start-page: 282 issue: 3 year: 1999 ident: 2497_CR30 publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a009804 – ident: 2497_CR12 doi: 10.1016/j.jvacx.2023.100264 – volume: 37 start-page: 226 issue: 2 year: 2019 ident: 2497_CR25 publication-title: Vaccine doi: 10.1016/j.vaccine.2018.11.056 – ident: 2497_CR10 doi: 10.1016/j.ijid.2015.05.003 – volume: 46 start-page: 1 year: 1997 ident: 2497_CR2 publication-title: MMWR Morb Mortal Wkly Rep |
| SSID | ssj0017853 |
| Score | 2.4037697 |
| Snippet | Background
Infection caused by Streptococcus pneumoniae, mainly invasive pneumococcal disease (IPD) and pneumococcal pneumonia (PP), are a major public health... Infection caused by Streptococcus pneumoniae, mainly invasive pneumococcal disease (IPD) and pneumococcal pneumonia (PP), are a major public health problem... Background Infection caused by Streptococcus pneumoniae, mainly invasive pneumococcal disease (IPD) and pneumococcal pneumonia (PP), are a major public health... BackgroundInfection caused by Streptococcus pneumoniae, mainly invasive pneumococcal disease (IPD) and pneumococcal pneumonia (PP), are a major public health... Abstract Background Infection caused by Streptococcus pneumoniae, mainly invasive pneumococcal disease (IPD) and pneumococcal pneumonia (PP), are a major... |
| SourceID | doaj unpaywall pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 200 |
| SubjectTerms | Adults Aged Aged patients Alcoholism Antigens Blood cancer Cardiovascular disease Care and treatment Chronic illnesses Chronic infection Codes Cohort Studies Comorbidity Critical Care Medicine Demographic aspects Diabetes Diabetes mellitus Diagnosis Dosage and administration Fatalities Health aspects Heart diseases Hematology HIV Hospitalization Hospitals Human immunodeficiency virus Humans Immunization Immunocompromised host Incidence Influenza Intensive Internal Medicine Kidney diseases Liver diseases Lung diseases Medicine Medicine & Public Health Middle Aged Mortality Multimorbidity Neoplasms - complications Older people Pneumococcal Infections - epidemiology Pneumococcal pneumonia Pneumococcal vaccine Pneumococcal Vaccines Pneumology/Respiratory System Pneumonia Pneumonia, Pneumococcal Pneumonia, Pneumococcal - epidemiology Pneumonia, Pneumococcal - prevention & control Population Population studies Population-based studies Prevention Primary care Public health Pulmonology Respiratory diseases Retrospective Studies Risk Factors Streptococcus infections Vaccines |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LbxMxELZQDzwOiDeBgoyExIFa3YfX9nIriKpCKicq5Wb5tSJS6kQkEeq_74zXu2RBKhw4JutNdjzPT-P9hpC3kNRtiZytUCsoxrlvmAWMzaTtIPgFyPipo3v-VZxd8C_zZr436gvPhPX0wP3GHXOrVDC1k1D588o0bRC1q30h2q42yiXgU6h2AFO5fyAhCw2vyChxvCmxn8YgPzGkyJOsmqShxNb_Z0zeS0q_H5gcu6b3yJ1dXJurn2a53EtMpw_I_VxR0pNekofkVoiPyO3z3DN_TOYQAvrJodRET_EsOc1Tduiqo-sYdpcrCIugrPwhLgxdRJqoOTYfqKHrccoXw6znaSKlfUIuTj9_-3TG8jwF5kShtky6wKsuKPDyQgKO6FTArh73xgOu6DrZmLLx3Dok6BG-ktYWVeo1tr5rrK2fkoO4iuE5oZUzwrQKvBfqqc7WrcfzYVw2QdXGcT4j5bC92mWycZx5sdQJdCihe5VoUIlOKtHVjLwf71n3VBs3rv6IWhtXIk12-gKMR2fj0X8znhl5hzrX6MzweM7kdxJASKTF0icScLoE1AcCHU5WghO66eXBanQOAhsNaBbiKeA3-J8342W8Ew-2xbDapTVcYNXbzsiz3shGkbCjCvU6iKom5jeReXolLr4nivASoaNo4EePBkv99Vw3berRaM3_oIMX_0MHL8ndKjmmYIU6JAfbH7vwCgq9rX2dfPoaHUZIqA priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3ra9RAEF_qFXwgovV1WmUFwQ926SXZbDaCSCstReghYuG-LfuKHpzJ2btD_O-d2WzSRuHw42U3Rybzzsz-hpDX4NRNgpitECtIxrnLmYEcmxWmAuPnweOHiu75VJxd8E-zfLZDpt1ZGGyr7GxiMNSusfiN_BBSAxBOCIaTD8ufDKdGYXW1G6Gh42gF9z5AjN0guykiY43I7vHJ9POXvq5QgHfqjs5IcbhKsM7GwG8xhM4rWDpwTwHF_19bfc1Z_d1I2VdT75Bbm3qpf__Si8U1h3V6n9yLkSY9akXjAdnx9R65eR5r6XvkbvvFjrYHkR6SGZiKdsIo1bWj2HNO4zQe2lR0WfvNjwbMJzA1_qjnms5rGiA8Vu-opst-GhhD7-hoAK99RC5OT75-PGNx7gKzYiLXrLCep5WXYA0mBeQblfRY_eNOO8g_qqrIdZI7biwC-QiXFsZM0lCTLF2VG5M9JqO6qf1TQlOrhS4laDnEXZXJSod9ZLzIvcy05XxMku51KxtByXE2xkKF5EQK1bJIAYtUYJFKx-Rtf8-yheTYuvsYudjvRDjtcKG5_KaidipupPQ6swWklzzVeelFZjM3EWWVaWmTMXmDMqBQ6eHxrI5nF4BIhM9SRwXk8wVkh0DQ_mAnKKsdLndSpKKxWKkr0R6TV_0y3okNcLVvNmEPFxgdl2PypBW6niSsvEJcD6TKgTgOaB6u1PPvAUo8wRRT5PCnB53kXj3Xtpd60Ev3f_Dg2Xaqn5PbaVBBwSZyn4zWlxv_AkK9tXkZ9fcPIqNL3A priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1baxQxFA7SgtoH8e5qlQiCDzY4l0yS8a0WSxHqk4V9C7kNLqzZxd2l9N_3nEx2uqNS9HEmycycOXdO8h1C3oFTtyVitkKsoBjnvmEWcmwmbQfGL4DHTxXd82_i7IJ_nTbTDJODZ2F26_elEh9XJVbCGHgWhuB2koG53QcnJVJhVpwMFQMJfmd7KOav60aOJ-Hz_2mFd9zQ71skhzrpAbm3iUtzdWnm8x1XdPqQPMgxJD3umf6I3AnxMbl7nqvkT8gUlL7vFUpN9BR3j9PcV4cuOrqMYfNzAYYQ2JMv4szQWaQJjGP1iRq6HPp6MfRzniYY2qfk4vTL95MzljsoMCcKtWbSBV51QYFeFxIyh04FrONxbzxkEl0nG1M2nluHkDzCV9LaokrVxdZ3jbX1M7IXFzG8ILRyRphWgb5CBNXZuvW4I4zLJqjaOM4npNz-Xu0yvDh2uZjrlGYooXuWaGCJTizR1YR8GNYse3CNW2d_Rq4NMxEYO90AedFZzzS3SgVTOwmJIq9M0wZRu9oXou1qo1w5Ie-R5xrVFz7PmXwKAYhEICx9LCEzl5DnAUGHo5mgdm48vJUandV-pSF_BQsKGRu85-0wjCtxK1sMi02awwXGue2EPO-FbCAJa6gQoQOpaiR-I5rHI3H2I4GCl5gsigYeerSV1Jvvuu2nHg3S_A88ePl_T39F7ldJBQUr1CHZW__ahNcQxK3tm6S913HUOUU priority: 102 providerName: Springer Nature – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELZQV-Jx4P0oLMhISBxYd5vEsR1uBbFaIe2KA5XKybIdByrSJGobIfj1jB03NAtagcSxsa1mnJlvPBrPNwi9AKeuI8fZCmcFQSjNU6IhxiZcFwB-Fjy-z-ienbPTOX2_SBehHZCrhdEr07TlCjzBZL_-vOzKG1z7BLs-bvKis3bBjjeRS5URcD3Esd9xAnh8wFI4mI_Qwfz8w-yTry_iEYkpY7uymT8uHLgmz-D_O07vOaqLlyj7TOoNdK2tGvX9myrLPWd1cguVOzG7OypfJ-1WT8yPCwyQ_2kfbqOb4VCLZ50W3kFXbHUXXT0Laft7aAEo1DUvxarKsbvOjkOjH1wXuKlsu6oBmUFfwo9qqfCywp4dZPMaK9z0jcaIc7w59ry499H85N3Ht6cktHQghk3FlnBjaVxYAUAz5RDKFMK6xCLNVQ6hTVHwVEVpTrVxHEEsj7nW09inO7O8SLVOHqBRVVf2EcKxUUxlAgAEjnSFTrLcXVGjPLUiUYbSMYp2X1OawHfu2m6U0sc9gsluyyRsmfRbJuMxetWvaTq2j0tnv3FK0s90TN3-Qb3-LIPhS6qFsCoxHCJXGqs0sywxST5lWZEoYaIxeulUTDo8gdczKpRFgJCOmUvOeBonHAJPEOhwMBNwwAyHd0oqAw5tJATUAOkQQsL_PO-H3Up3t66ydevnUOYO3tkYPex0uhfJJXUhZABRxUDbBzIPR6rlF89SHrnoFQxxjI52hvHrvS7b1KPeeP7iGzz-t-lP0PXYmwgjU3GIRtt1a5_CqXKrnwW0-AlfwGv0 priority: 102 providerName: Unpaywall |
| Title | Incidence and risk factors of pneumococcal pneumonia in adults: a population-based study |
| URI | https://link.springer.com/article/10.1186/s12890-023-02497-2 https://www.ncbi.nlm.nih.gov/pubmed/37291502 https://www.proquest.com/docview/2827038261 https://www.proquest.com/docview/2824685119 https://pubmed.ncbi.nlm.nih.gov/PMC10251659 https://bmcpulmmed.biomedcentral.com/counter/pdf/10.1186/s12890-023-02497-2 https://doaj.org/article/4b88ea3c714442a59e63c3d069f3a8c1 |
| UnpaywallVersion | publishedVersion |
| Volume | 23 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: Open Access: BioMedCentral Open Access Titles customDbUrl: eissn: 1471-2466 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017853 issn: 1471-2466 databaseCode: RBZ dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1471-2466 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017853 issn: 1471-2466 databaseCode: KQ8 dateStart: 20010101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1471-2466 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017853 issn: 1471-2466 databaseCode: KQ8 dateStart: 20010901 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1471-2466 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017853 issn: 1471-2466 databaseCode: DOA dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1471-2466 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017853 issn: 1471-2466 databaseCode: DIK dateStart: 20010101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1471-2466 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017853 issn: 1471-2466 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1471-2466 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017853 issn: 1471-2466 databaseCode: M~E dateStart: 20010101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1471-2466 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017853 issn: 1471-2466 databaseCode: RPM dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1471-2466 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017853 issn: 1471-2466 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical Collection customDbUrl: eissn: 1471-2466 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017853 issn: 1471-2466 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 1471-2466 dateEnd: 20250131 omitProxy: true ssIdentifier: ssj0017853 issn: 1471-2466 databaseCode: M48 dateStart: 20010901 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal – providerCode: PRVAVX databaseName: Springer Nature HAS Fully OA customDbUrl: eissn: 1471-2466 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017853 issn: 1471-2466 databaseCode: AAJSJ dateStart: 20011201 isFulltext: true titleUrlDefault: https://www.springernature.com providerName: Springer Nature – providerCode: PRVAVX databaseName: Springer Nature OA Free Journals customDbUrl: eissn: 1471-2466 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017853 issn: 1471-2466 databaseCode: C6C dateStart: 20010112 isFulltext: true titleUrlDefault: http://www.springeropen.com/ providerName: Springer Nature |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLbGJnF5QNwpjMpISDwwj1wc20FCqK02TUitpolKhRfLdhyoVJLSi2D_nmPnsgWmCV4qpXbSOOf69TjfQegVBHUdOs5WyBUEoTRLiAaMTbjOwflZiPi-ojuesJMp_ThLZjuoaXdUP8D1ldDO9ZOarhaHv36cfwCDf-8NXrC369BVywhEH-II8DgBl7wHkSp1rRzG9KKqwIVnpQzBIZOIMta8RHPlNTqByvP5_-21L4WtP7dUtnXVO-jWtliq859qsbgUuo7vobt1zokHlZLcRzu2eIBujuuq-kM0AydR9RbFqsiw222O6z48uMzxsrDb7yU4ThBnfVDMFZ4X2JN3rN9hhZdtHzDi4mKGPW3tIzQ9Pvo0OiF1xwViWCA2hBtLo9wK8AMBB6SRC-vqfjRTGSCPPOeJCpOMauMofFgWca2DyFcj0yxPtI4fo92iLOxThCOjmEoF2DdkXLmO08ztIKM8sSJWhtIeCpvHK01NR-66YiykhyWCyUokEkQivUhk1ENv2nOWFRnHtbOHTmrtTEek7b8oV19lbZeSaiGsig0HYEkjlaSWxSbOApbmsRIm7KHXTubSKSDcnlH1WwuwSEecJQcckDwHXAgL2u_MBDM13eFGa2Sj5RLwLnhcQHjwOy_bYXem2_pW2HLr51Dm8uK0h55UStYuydVcIaOHpYqO-nXW3B0p5t88iXjowCVL4KIHjaZe3Nd1D_Wg1eZ_kMGz_5LYc3Q78hbISCD20e5mtbUvIOfb6D66wWe8j_aGR5PTMzgasVHf_3_S9yYOn2fDLzA-nZwOPv8GOsFQTw |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fb9MwELbGJjEQQjB-FQYYCcQDs9YkTuIgTWiDTR1bK4Q2qW_GsR2oVJKytpr2z_G3cec42QpSxcseWztRLnf-7i5nf0fIa3DqeYCcrRArCMa5iVkOOTZL8wLAz4LHdxXd_iDpnfLPw3i4Qn43Z2FwW2WDiQ6oTaXxG_k2pAZgnBAMBx8mvxh2jcLqatNCQ_nWCmbHUYz5gx1H9uIcUrjpzuEn0PebMDzYP_nYY77LANNJV8xYqi0PCyvA9rspRNeFsFjr4kYZiLaLIo1VEBuea6StSUyY5nk3dBW4zBRxnkdw3xtkjUc8g-RvbW9_8OVrW8dIwRs2R3VEsj0NsK7HwE8ypOpLWbjgDl3XgH99wxXn-PfGzbZ6e5usz8uJujhX4_EVB3lwj9z1kS3drU3xPlmx5Qa52fe1-w1yp_5CSOuDTw_IEKCp7mhKVWko7nGnvvsPrQo6Ke38ZwVwDUbkf5QjRUcldZQh0_dU0UnbfYyhNzbUkeU-JKfXooFHZLWsSvuE0FCrRGUCUAXivCKPMoP71ngaWxEpzXmHBM3rltqToGMvjrF0yZBIZK0iCSqSTkUy7JB37TWTmgJk6ew91GI7E-m73R_V2Xfp0UDyXAirIp1COstDFWc2iXRkuklWRErooEPeog1IBBl4PK38WQkQEum65G4ah1EK2SgItLkwE8BBLw43ViQ9OE3l5VLqkFftMF6JG-5KW83dHJ5gNJ51yOPa6FqRsNILeQSIKhbMcUHmxZFy9MNRlweY0iYx3HSrsdzL51r2Urda6_4PHTxdLvVLst476R_L48PB0TNyK3TLMWFdsUlWZ2dz-xzCzFn-wq9lSr5dN3z8AYERh_w |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLbQkAZ7QFy3wgAjIfHArDWJYzu8jUI1Lpt4YFLfLN8ClYpbra0Q_55znDQ0gCZ4TGwnOTl3Hfs7hDwHp24zxGyFWEExzn3JLOTYTNoajF8Aj58qumfn4vSCv5-Uk61T_Gm3-6Yk2ZxpQJSmuDpe-LpRcSWOlxnWxxj4G4aQd5KBEb7OwbthD4ORGHV1BAneaHNU5q_reu4oofb_aZu3nNPvGye76ukeubGOC_Pju5nNthzU-Da51UaW9KQRhTvkWoh3ye5ZWzu_RyZgCpoOotRET3FPOW277dB5TRcxrL_NwTwC09qLODV0GmmC6Fi-ooYuum5fDL2fpwmc9j65GL_9PDplbV8F5sRQrZh0ged1UKDtQwn5RK0CVve4Nx7yi7qWpclKz61DoB7hc2ntME81x8rXpbXFA7IT5zEcEJo7I0ylQIshrqptUXncJ8ZlGVRhHOcDkm1-r3Yt6Dj2vpjplHwooRuWaGCJTizR-YC87NYsGsiNK2e_Rq51MxEuO92YX37RrfZpbpUKpnAS0keem7IKonCFH4qqLoxy2YC8QJ5rVGr4PGfaswlAJMJj6RMJ-bqE7A8IOuzNBGV0_eGN1OjWGCw1ZLVgVyGPg_c864ZxJW5wi2G-TnO4wOi3GpD9Rsg6krCyCnE7kKp64tejuT8Sp18TVHiGKaQo4aFHG0n99V1X_dSjTpr_gQcP_-_pT8nupzdj_fHd-YdH5GaetFGwoTokO6vLdXgMUd7KPkmK_BMJSUR7 |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELZQV-Jx4P0oLMhISBxYd5vEsR1uBbFaIe2KA5XKybIdByrSJGobIfj1jB03NAtagcSxsa1mnJlvPBrPNwi9AKeuI8fZCmcFQSjNU6IhxiZcFwB-Fjy-z-ienbPTOX2_SBehHZCrhdEr07TlCjzBZL_-vOzKG1z7BLs-bvKis3bBjjeRS5URcD3Esd9xAnh8wFI4mI_Qwfz8w-yTry_iEYkpY7uymT8uHLgmz-D_O07vOaqLlyj7TOoNdK2tGvX9myrLPWd1cguVOzG7OypfJ-1WT8yPCwyQ_2kfbqOb4VCLZ50W3kFXbHUXXT0Laft7aAEo1DUvxarKsbvOjkOjH1wXuKlsu6oBmUFfwo9qqfCywp4dZPMaK9z0jcaIc7w59ry499H85N3Ht6cktHQghk3FlnBjaVxYAUAz5RDKFMK6xCLNVQ6hTVHwVEVpTrVxHEEsj7nW09inO7O8SLVOHqBRVVf2EcKxUUxlAgAEjnSFTrLcXVGjPLUiUYbSMYp2X1OawHfu2m6U0sc9gsluyyRsmfRbJuMxetWvaTq2j0tnv3FK0s90TN3-Qb3-LIPhS6qFsCoxHCJXGqs0sywxST5lWZEoYaIxeulUTDo8gdczKpRFgJCOmUvOeBonHAJPEOhwMBNwwAyHd0oqAw5tJATUAOkQQsL_PO-H3Up3t66ydevnUOYO3tkYPex0uhfJJXUhZABRxUDbBzIPR6rlF89SHrnoFQxxjI52hvHrvS7b1KPeeP7iGzz-t-lP0PXYmwgjU3GIRtt1a5_CqXKrnwW0-AlfwGv0 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Incidence+and+risk+factors+of+pneumococcal+pneumonia+in+adults%3A+a+population-based+study&rft.jtitle=BMC+pulmonary+medicine&rft.au=Ochoa-Gondar%2C+Olga&rft.au=Torras-Vives%2C+Ver%C3%B3nica&rft.au=de+Diego-Cabanes%2C+Cinta&rft.au=Satu%C3%A9-Gracia%2C+Eva+M.&rft.date=2023-06-08&rft.issn=1471-2466&rft.eissn=1471-2466&rft.volume=23&rft.issue=1&rft_id=info:doi/10.1186%2Fs12890-023-02497-2&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12890_023_02497_2 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2466&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2466&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2466&client=summon |